Botanix Announces Expansion of Permetrex License
Filed with ASX · · 2 pages · English
Watch Botanix Pharmaceuticals' latest callBotanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call · Replay · Mar 2Read the transcript of Botanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings CallBotanix Pharmaceuticals Limited on 6ix
Earlier from Botanix Pharmaceuticals
- Quarterly Cashflow Report
- Botanix Announces Positive Human Trial Data
- Botanix Accelerates Clinical Program with First Human Study
- DEA Scheduling Decision Supports Botanix Approach
- Botanix Secures Commercial-Scale Synthetic Cannabidiol
Later from Botanix Pharmaceuticals
- Botanix Announces Filing of New Permetrex Product Patents
- Export and Import Approvals for Clinical Studies Received
- Botanix Receives Approval for Synthetic Cannabidiol Trial
- Suspension from Official Quotation
- Reinstatement to official quotation
Follow Botanix Pharmaceuticals into a list and get an email when it puts out news.
Follow Botanix Pharmaceuticals